Scholar Rock SRRK Enterprise value

Enterprise value at other companies

BiogenBIIB

$38.17B+70.8%

Edgewise Therapeutics, Inc.EWTX

$3.35B+63.5%

PTC TherapeuticsPTCT

$5.2B+77.3%

Dyne Therapeutics, Inc.DYN

$2.41B+228%

Solid Biosciences Inc.SLDB

$844.27M+224%

CalAmpCAMP

$130.25M+246%

FAQ

What is Scholar Rock's enterprise value?

Scholar Rock (SRRK) reported enterprise value of $6.36B in Q2 2026.

How has Scholar Rock's enterprise value changed year-over-year?

Scholar Rock's enterprise value increased by 106.4% year-over-year, from $3.08B to $6.36B.

What is the long-term trend for Scholar Rock's enterprise value?

Over 5 years (2020 to 2025), Scholar Rock's enterprise value has grown at a 21.7% compound annual growth rate (CAGR), from $1.6B to $4.28B.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.